EUVIMEDEUVIMED entdecken
Crossref

Clinical and Genetic Spectrum of Patients With Mitochondrial Disease in a Pediatric Egyptian Cohort: Novel Variants and Phenotypic Expansion

Hebatallah M Hassaan iD, Angela Pyle iD, Nihal Almenabawy iD, Fiona M Robertson, Nour Elkhateeb iD, Marian Y Girgis, Iman Gamal El Din Mahmoud, Fawzia Amer iD, Mona Samaha, Yara Shaheen iD, Walaa ElNaggar iD, Doaa Abdoh und 5 weitere

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.63881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Hebatallah M Hassaan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Genetic Division, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Phenotype, DNA, Mitochondrial. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Wellcome Centre for Mitochondrial Research, Mitochondrial Disease Patient Cohort, Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial disorders exhibit clinical and genetic diversity. Nearly 400 distinct genes, located in both the mitochondrial and nuclear genomes, harbor pathogenic variants that can produce a broad spectrum of mitochondrial diseases. This work aims to explore the genetic etiology of a cohort of Egyptian pediatric patients who were clinically suspected of having a mitochondrial disorder. A total of 49 patients from 44 unrelated families were studied. Selection criteria included age below 18 years and meeting Morava criteria (a score ≥ 3). The mitochondrial disease criteria (MDC) have been developed to quantify the clinical picture and evaluate the probability of an underlying mitochondrial disorder Exome sequencing, including mitochondrial genome sequencing, was carried out for each participant. Causative variants likely responsible for the phenotypes were identified in 68% of the study population. The mitochondrial subgroup constituted 41% of the studied population with a median age of 4 years. No primary pathogenic variants in mitochondrial DNA were detected. Pathogenic or likely pathogenic variants in eight mitochondrial genes were identified in 78% of the mitochondrial cohort. Additionally, seven novel variants were identified. Nonmitochondrial diagnoses accounted for 27% of the study population. In 32% of cases, disease‐causing variants were not identified. The current study underscores the diverse phenotypic and genetic landscape of mitochondrial disorders among Egyptian patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesPhenotypeDNA, MitochondrialHumansChildFemaleMaleChild, PreschoolEgyptAdolescentInfantMutationGenome, MitochondrialExome SequencingCohort StudiesGenetic VariationGenetic Predisposition to DiseaseMitochondria

Stichwörter der Autor:innen

exome sequencinggenemitochondrial diseasesvariants

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Pediatric Department, Genetic Division, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Pediatric Department, Neurology and Metabolic Division, Faculty of Medicine Cairo University, Cairo, Egypt.
  • Department of Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

ORCID-Profile: Hebatallah M Hassaan, Angela Pyle, Nihal Almenabawy, Nour Elkhateeb, Fawzia Amer, Yara Shaheen, Walaa ElNaggar, Dina Ahmed Mehaney, Robert W Taylor, Robert McFarland, Laila Selim

Förderung

  • Wellcome Centre for Mitochondrial Research
  • Mitochondrial Disease Patient Cohort
  • Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease
  • The Lily Foundation
  • NIHR Biomedical Research Centre
  • Pathological Society of Great Britain and Ireland
  • Mito Foundation
  • British Council

Zitieren

APA

Hassaan, H. M., Pyle, A., Almenabawy, N., Robertson, F. M., Elkhateeb, N., Girgis, M. Y., Mahmoud, I. G. E. D., Amer, F., Samaha, M., Shaheen, Y., ElNaggar, W., Abdoh, D., Mehaney, D. A., Meguid, I. E. A., Taylor, R. W., McFarland, R., & Selim, L. (2025). Clinical and Genetic Spectrum of Patients With Mitochondrial Disease in a Pediatric Egyptian Cohort: Novel Variants and Phenotypic Expansion. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63881

Vancouver

Hassaan HM, Pyle A, Almenabawy N, Robertson FM, Elkhateeb N, Girgis MY, et al. Clinical and Genetic Spectrum of Patients With Mitochondrial Disease in a Pediatric Egyptian Cohort: Novel Variants and Phenotypic Expansion. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63881

BibTeX
@article{Hassaan2025,
  author = {Hassaan, Hebatallah M and Pyle, Angela and Almenabawy, Nihal and Robertson, Fiona M and Elkhateeb, Nour and Girgis, Marian Y and Mahmoud, Iman Gamal El Din and Amer, Fawzia and Samaha, Mona and Shaheen, Yara and ElNaggar, Walaa and Abdoh, Doaa and Mehaney, Dina Ahmed and Meguid, Iman Ehsan Abdel and Taylor, Robert W and McFarland, Robert and Selim, Laila},
  title = {Clinical and Genetic Spectrum of Patients With Mitochondrial Disease in a Pediatric Egyptian Cohort: Novel Variants and Phenotypic Expansion},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.63881}
}
Kostenlos starten →